Abstract LB-010: Molecular analysis for therapy choice (NCI-MATCH, EAY131) arm Z1B: Phase II trial of palbociclib for CCND1, 2 or 3 amplified tumors

Clark, Amy S.; Hong, Fangxin; Finn, Richard S.; DeMichele, Angela; Mitchell, Edith P.; Zweibel, James; Arnaldez, Fernanda I.; McShane, Lisa M.; Li, Shuli; Gray, Robert J.

doi:10.1158/1538-7445.am2019-lb-010

Abstract LB-010: Molecular analysis for therapy choice (NCI-MATCH, EAY131) arm Z1B: Phase II trial of palbociclib for CCND1, 2 or 3 amplified tumors

NobleIDNI6P50W71R71S44

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/80933ECF.svg?ark=w1%2F20260521%2F80933ECF&value=id)](https://nobleid.org/work/w1/20260521/80933ECF)

ARK Inflections

Metadata (JSON)Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Abstract LB-010: Molecular analysis for therapy choice (NCI-MATCH, EAY131) arm Z1B: Phase II trial of palbociclib for CCND1, 2 or 3 amplified tumors

NobleIDNI6P50W71R71S44

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/80933ECF.svg?ark=w1%2F20260521%2F80933ECF&value=id)](https://nobleid.org/work/w1/20260521/80933ECF)

ARK Inflections

Metadata (JSON)Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work